Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Healthcare | 16.97% |
| 3 | Consumer Discretionary | 12.86% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Manitowoc
MTW
$749M
| $1.3M | ﹤0.01% |
68,900
-80,249
| -54% | -$1.29M |
|
2302
Rocky Brands
RCKY
$358M
| $1.3M | ﹤0.01% |
61,735
-6,500
| -10% | -$143K |
|
|
LONA
2303
LeonaBio Inc
LONA
$76.3M
| $1.29M | ﹤0.01% |
43,880
+12,693
| +41% | +$362K |
|
2304
Heritage Insurance Holdings
HRTG
$1,000M
| $1.29M | ﹤0.01% |
336,129
-25,270
| -7% | -$101K |
|
2305
Westamerica Bancorp
WABC
$1.39B
| $1.29M | ﹤0.01% |
33,701
-2,630
| -7% | -$105K |
|
|
AAIC
2306
DELISTED
Arlington Asset Investment Corp.
AAIC
| $1.29M | ﹤0.01% |
278,788
+14,300
| +5% | +$46.6K |
|
2307
iShares Convertible Bond ETF
ICVT
$7.64B
| $1.29M | ﹤0.01% |
+16,900
| New | +$1.23M |
|
|
SY
2308
So-Young International
SY
$221M
| $1.29M | ﹤0.01% |
699,585
+39,557
| +6% | +$94.8K |
|
2309
Editas Medicine
EDIT
$425M
| $1.29M | ﹤0.01% |
+156,300
| New | +$1.36M |
|
|
KALV
2310
DELISTED
KalVista Pharmaceuticals
KALV
| $1.29M | ﹤0.01% |
142,928
+62,328
| +77% | +$575K |
|
2311
Chemung Financial Corp
CHMG
$404M
| $1.28M | ﹤0.01% |
33,322
+1,014
| +3% | +$38.6K |
|
2312
Network-1 Technologies
NTIP
$35.9M
| $1.28M | ﹤0.01% |
553,244
-8,600
| -2% | -$19.2K |
|
|
PTVE
2313
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.28M | ﹤0.01% |
168,800
-3,000
| -2% | -$22.9K |
|
2314
Magnachip Semiconductor
MX
$135M
| $1.28M | ﹤0.01% |
114,188
-22,399
| -16% | -$219K |
|
2315
ReposiTrak
TRAK
$156M
| $1.28M | ﹤0.01% |
126,563
-12,300
| -9% | -$92.4K |
|
|
NOTV
2316
DELISTED
Inotiv
NOTV
| $1.28M | ﹤0.01% |
267,565
-505,500
| -65% | -$2.79M |
|
2317
CPI Card Group
PMTS
$332M
| $1.27M | ﹤0.01% |
54,700
+9,400
| +21% | +$301K |
|
2318
AXT Inc
AXTI
$5.22B
| $1.27M | ﹤0.01% |
369,012
+151,403
| +70% | +$511K |
|
|
PMD
2319
DELISTED
Psychemedics Corporation
PMD
| $1.27M | ﹤0.01% |
277,963
-3,300
| -1% | -$16.7K |
|
2320
Origin Bancorp
OBK
$1.68B
| $1.27M | ﹤0.01% |
43,200
-1,200
| -3% | -$35.9K |
|
|
TRHC
2321
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.26M | ﹤0.01% |
153,200
+113,500
| +286% | +$679K |
|
2322
Xponential Fitness
XPOF
$209M
| $1.26M | ﹤0.01% |
73,200
-160,600
| -69% | -$4.55M |
|
2323
KVH Industries
KVHI
$143M
| $1.26M | ﹤0.01% |
138,000
+2,400
| +2% | +$24.2K |
|
2324
Embotelladora Andina Series A
AKO.A
$3.75B
| $1.26M | ﹤0.01% |
102,400
-1,400
| -1% | -$17.4K |
|
2325
Latham Group
SWIM
$879M
| $1.25M | ﹤0.01% |
338,400
-49,400
| -13% | -$151K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.